{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T23:16:15Z","timestamp":1769901375515,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,3,1]]},"DOI":"10.1038\/sj.bmt.1702854","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:50:37Z","timestamp":1031154637000},"page":"627-633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin"],"prefix":"10.1038","volume":"27","author":[{"given":"M","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LA","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Swinnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MR","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Bambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SH","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZP","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MS","family":"Czuczman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JL","family":"Slack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Wetzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Herzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Schriber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"PL","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,4,23]]},"reference":[{"key":"BF1702854_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE et al. Venoocclusive disease of the liver after marrow transplantation: diagnosis, incidence, and predisposing factors Hepatology 1984 4: 116\u2013122","journal-title":"Hepatology"},{"key":"BF1702854_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Ann Intern Med 1993 118: 255\u2013267","journal-title":"Ann Intern Med"},{"key":"BF1702854_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation Transplantation 1987 44: 778\u2013783","journal-title":"Transplantation"},{"key":"BF1702854_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00007890-198506000-00005","volume":"39","author":"GB McDonald","year":"1985","unstructured":"McDonald GB, Sharma P, Matthews DE et al. The clinical course of 53 patients with veno-occlusive disease of the liver after marrow transplantation Transplantation 1985 39: 603\u2013608","journal-title":"Transplantation"},{"key":"BF1702854_CR5","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/0016-5085(80)90911-7","volume":"79","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, McDonald GB, Matthews D et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation Gastroenterology 1980 79: 1178\u20131191","journal-title":"Gastroenterology"},{"key":"BF1702854_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG et al. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms Hepatology 1994 19: 1171\u20131181","journal-title":"Hepatology"},{"key":"BF1702854_CR7","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","volume":"79","author":"M Attal","year":"1992","unstructured":"Attal M, Huguet F, Rubie H et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial Blood 1992 79: 2834\u20132840","journal-title":"Blood"},{"key":"BF1702854_CR8","first-page":"185","volume":"18","author":"J Rosenthal","year":"1996","unstructured":"Rosenthal J, Sender L, Secola R et al. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation Bone Marrow Transplant 1996 18: 185\u2013191","journal-title":"Bone Marrow Transplant"},{"key":"BF1702854_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","volume":"47","author":"L Marsa-Vila","year":"1991","unstructured":"Marsa-Vila L, Gorin NC, Laporte JP et al. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation Eur J Haematol 1991 47: 346\u2013354","journal-title":"Eur J Haematol"},{"key":"BF1702854_CR10","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood.V92.7.2599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation Blood 1998 92: 2599\u20133604","journal-title":"Blood"},{"key":"BF1702854_CR11","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V80.8.2149.2149","volume":"80","author":"JY Cahn","year":"1992","unstructured":"Cahn JY, Flesch M, Brion A et al. Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin? Blood 1992 80: 2149\u20132150","journal-title":"Blood"},{"key":"BF1702854_CR12","first-page":"407","volume":"5","author":"SI Bearman","year":"1990","unstructured":"Bearman SI, Hinds MS, Wolford JL . A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation Bone Marrow Transplant 1990 5: 407\u2013411","journal-title":"Bone Marrow Transplant"},{"key":"BF1702854_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","volume":"74","author":"E Gluckman","year":"1990","unstructured":"Gluckman E, Jolivet I, Scrobohaci ML et al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation Br J Haematol 1990 74: 277\u2013281","journal-title":"Br J Haematol"},{"key":"BF1702854_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","volume":"84","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Shen DD, Hinds MS et al. A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation Br J Haematol 1993 84: 724\u2013730","journal-title":"Br J Haematol"},{"key":"BF1702854_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJM199204093261502","volume":"326","author":"RD Hull","year":"1992","unstructured":"Hull RD, Raskob GE, Pineo GF et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis New Engl J Med 1992 326: 975\u2013982","journal-title":"New Engl J Med"},{"key":"BF1702854_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7326\/0003-4819-121-2-199407150-00001","volume":"121","author":"TE Spiro","year":"1994","unstructured":"Spiro TE, Johnson GJ, Christie MJ et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery Ann Intern Med 1994 121: 81\u201389","journal-title":"Ann Intern Med"},{"key":"BF1702854_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","volume":"61","author":"R Or","year":"1996","unstructured":"Or R, Nagler A, Shpilberg O et al. Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients Transplantation 1996 61: 1067\u20131071","journal-title":"Transplantation"},{"key":"BF1702854_CR18","first-page":"413a","volume":"88","author":"J Schriber","year":"1996","unstructured":"Schriber J, Milk BJ, Baer MR et al. A randomized phase II trial comparing heparin (Hep) +\/\u2212 Prostaglandin E1 (PG) to prevent hepatotoxicity (HT) following bone marrow transplantation (BMT): preliminary results Blood 1996 88: (Suppl. 1) 413a (Abstr. 1642)","journal-title":"Blood"},{"key":"BF1702854_CR19","first-page":"322","volume":"5","author":"A Alidina","year":"1999","unstructured":"Alidina A, Lawrence D, Ford LA et al. Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors Biol BMT 1999 5: 322\u2013327","journal-title":"Biol BMT"},{"key":"BF1702854_CR20","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1182\/blood.V85.5.1391.bloodjournal8551391","volume":"85","author":"RA Brown","year":"1995","unstructured":"Brown RA, Wolff SN, Fay JW et al. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group Blood 1995 85: 1391\u20131395","journal-title":"Blood"},{"key":"BF1702854_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1200\/JCO.1989.7.2.179","volume":"7","author":"S Jagannath","year":"1989","unstructured":"Jagannath S, Armitage JO, Dicke KA et al. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease J Clin Oncol 1989 7: 179\u2013185","journal-title":"J Clin Oncol"},{"key":"BF1702854_CR22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","volume":"309","author":"GW Santos","year":"1983","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R . Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide New Engl J Med 1983 309: 1347\u20131353","journal-title":"New Engl J Med"},{"key":"BF1702854_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0140-6736(72)90292-9","volume":"1","author":"ED Thomas","year":"1972","unstructured":"Thomas ED, Storb R, Fefer A et al. Aplastic anaemia treated by marrow transplantation Lancet 1972 1: 284\u2013289","journal-title":"Lancet"},{"key":"BF1702854_CR24","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V80.7.1666.1666","volume":"80","author":"S Jagannath","year":"1992","unstructured":"Jagannath S, Vesole DH, Glenn L et al. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow transplantation and blood stem cell support Blood 1992 80: 1666\u20131672","journal-title":"Blood"},{"key":"BF1702854_CR25","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","volume":"80","author":"RA Nash","year":"1992","unstructured":"Nash RA, Pepe MS, Storb R et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate Blood 1992 80: 1838\u20131845","journal-title":"Blood"},{"key":"BF1702854_CR26","first-page":"553","volume":"3","author":"JD Shepherd","year":"1988","unstructured":"Shepherd JD, Shore TB, Reece DE et al. Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease Bone Marrow Transplant 1988 3: 553\u2013558","journal-title":"Bone Marrow Transplant"},{"key":"BF1702854_CR27","first-page":"102a","volume":"90","author":"A Alam","year":"1997","unstructured":"Alam A, Baer MR, Bernstein S et al. Phase II clinical trial of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplantation (alloBMT) Blood 1997 90: (Suppl. 1) 102a (Abstr. 449)","journal-title":"Blood"},{"key":"BF1702854_CR28","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","volume":"329","author":"NJ Chao","year":"1993","unstructured":"Chao NJ, Schmidt GM, Niland JC et al. Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisone for prophylaxis for acute graft-versus-host disease New Engl J Med 1993 329: 1225\u20131230","journal-title":"New Engl J Med"},{"key":"BF1702854_CR29","first-page":"2303","volume":"92","author":"V Ratanatarathorn","year":"1998","unstructured":"Ratanatarathorn V, Nash RA, Przepiorka D et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation Blood 1998 92: 2303\u20132314","journal-title":"Blood"},{"key":"BF1702854_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295\u2013304","journal-title":"Transplantation"},{"key":"BF1702854_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long-term clinico-pathologic study of 20 Seattle patients Am J Med 1980 69: 204\u2013217","journal-title":"Am J Med"},{"key":"BF1702854_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/sj.bmt.1702069","volume":"24","author":"J Schriber","year":"1999","unstructured":"Schriber J, Milk B, Shaw D et al. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation Bone Marrow Transplant 1999 24: 1311\u20131314","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702854","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:03:08Z","timestamp":1648072988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,3,1]]}},"alternative-id":["BF1702854"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702854","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,1]]},"assertion":[{"value":"28 November 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}